Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1255, 2000-01, pp. : 8-8
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Docetaxel plus gemcitabine shows antitumour efficacy in patients with advanced NSCLC
Inpharma, Vol. 1, Iss. 1280, 2001-01 ,pp. :
Access to resources
Recommend
Gemcitabine plus cisplatin for NSCLC
Inpharma, Vol. 1, Iss. 1222, 2000-01 ,pp. :
Erlotinib improves QOL in NSCLC
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 512, 2006-01 ,pp. :
Erlotinib improves QOL in NSCLC
Inpharma, Vol. 1, Iss. 1557, 2006-01 ,pp. :
Gemcitabine plus vinorelbine superior in NSCLC
Inpharma, Vol. 1, Iss. 1251, 2000-01 ,pp. :